Home
Race Oncology Ltd
ASX Code
RAC
Sector
Pharmaceuticals- Biotechnology & Life Sciences
Investor Centre
https://www.raceoncology.com/investors/
Website
https://www.raceoncology.com/
About
Race Oncology is an ASX listed precision oncology company with a Phase II/III cancer drug called Bisantrene. Bisantrene is a potent inhibitor of the Fat mass and obesity associated (FTO) protein.
News
| A precision oncology company |
| Race Oncology Limited (ASX:RAC) - Hidden Gems Webinar Presentation |